Wuhan Keqian Biology Co. Ltd. Reports Findings in Feline Panleukopenia Virus (Development of a recombinant Lactobacillus plantarum oral vaccine expressing VP2 protein for preventing feline panleukopenia virus).

MLA

“Wuhan Keqian Biology Co. Ltd. Reports Findings in Feline Panleukopenia Virus (Development of a Recombinant Lactobacillus Plantarum Oral Vaccine Expressing VP2 Protein for Preventing Feline Panleukopenia Virus).” Veterinary Week, Oct. 2024, p. 129. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180078508&authtype=sso&custid=ns315887.

APA

Wuhan Keqian Biology Co. Ltd. Reports Findings in Feline Panleukopenia Virus (Development of a recombinant Lactobacillus plantarum oral vaccine expressing VP2 protein for preventing feline panleukopenia virus). (2024). Veterinary Week, 129.

Chicago

“Wuhan Keqian Biology Co. Ltd. Reports Findings in Feline Panleukopenia Virus (Development of a Recombinant Lactobacillus Plantarum Oral Vaccine Expressing VP2 Protein for Preventing Feline Panleukopenia Virus).” 2024. Veterinary Week, October, 129. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180078508&authtype=sso&custid=ns315887.